Advertisement

Molecular Medicine

, Volume 14, Issue 5–6, pp 293–300 | Cite as

Several Regions in the Major Histocompatibility Complex Confer Risk for Anti-CCP-Antibody Positive Rheumatoid Arthritis, Independent of the DRB1 Locus

  • Hye-Soon Lee
  • Annette T. Lee
  • Lindsey A. Criswell
  • Michael F. Seldin
  • Christopher I. Amos
  • John P. Carulli
  • Cristina Navarrete
  • Elaine F. Remmers
  • Daniel L. Kastner
  • Robert M. Plenge
  • Wentian Li
  • Peter K. Gregersen
Research Article

Abstract

Recent evidence suggests that additional risk loci for RA are present in the major histocompatibility complex (MHC), independent of the class II HLA-DRB1 locus. We have now tested a total of 1,769 SNPs across 7.5Mb of the MHC located from 6p22.2 (26.03 Mb) to 6p21.32 (33.59 Mb) derived from the Illumina 550K Beadchip (Illumina, San Diego, CA, USA). For an initial analysis in the whole dataset (869 RA CCP + cases, 1,193 controls), the strongest association signal was observed in markers near the HLA-DRB1 locus, with additional evidence for association extending out into the Class I HLA region. To avoid confounding that may arise due to linkage disequilibrium with DRB1 alleles, we analyzed a subset of the data by matching cases and controls by DRB1 genotype (both alleles matched 1:1), yielding a set of 372 cases with 372 controls. This analysis revealed the presence of at least two regions of association with RA in the Class I region, independent of DRB1 genotype. SNP alleles found on the conserved A1-B8-DR3 (8.1) haplotype show the strongest evidence of positive association (P ~ 0.00005) clustered in the region around the HLA-C locus. In addition, we identified risk alleles that are not present on the 8.1 haplotype, with maximal association signals (P ~ 0.001–0.0027) located near the ZNF311 locus. This latter association is enriched in DRB1*0404 individuals. Finally, several additional association signals were found in the extreme centromeric portion of the MHC, in regions containing the DOB1, TAP2, DPB1, and COL11A2 genes. These data emphasize that further analysis of the MHC is likely to reveal genetic risk factors for rheumatoid arthritis that are independent of the DRB1 shared epitope alleles.

Notes

Acknowledgments

Support was provided by the National Institutes of Health, RO1-AR44222 and U19 IMAGEN. The research also was supported in part by the intramural program of the National Institute of Arthritis and Musculoskeletal and Skin Diseases, as well as the Eileen Ludwig Greenland Center for Rheumatoid Arthritis at the Feinstein Institute. LAC is supported by R01 AI065841.

Supplementary material

10020_2008_1405293_MOESM1_ESM.pdf (412 kb)
Several Regions in the Major Histocompatibility Complex Confer Risk for Anti-CCP-Antibody Positive Rheumatoid Arthritis, Independent of the DRB1 Locus

References

  1. 1.
    Firestein GS. (2003) Evolving concepts of rheumatoid arthritis. Nature. 423:356–61.CrossRefGoogle Scholar
  2. 2.
    Begovich AB et al. (2004) A missense single-nucleotide polymorphism in a gene encoding a protein tyrosine phosphatase (PTPN22) is associated with rheumatoid arthritis. Am. J. Hum. Genet. 75:330–7.CrossRefPubMedPubMedCentralGoogle Scholar
  3. 3.
    Suzuki A et al. (2003) Functional haplotypes of PADI4, encoding citrullinating enzyme peptidylarginine deiminase 4, are associated with rheumatoid arthritis. Nat. Genet. 34:395–402.CrossRefGoogle Scholar
  4. 4.
    Plenge RM et al. (2007) TRAF1-C5 as a risk locus for rheumatoid arthritis—a genomewide study. N. Eng. J. Med. 357:1199–209.CrossRefGoogle Scholar
  5. 5.
    Remmers EF et al. (2007) STAT4 and the risk of rheumatoid arthritis and systemic lupus erythematosus. N. Eng. J. Med. 357:977–86.CrossRefGoogle Scholar
  6. 6.
    Plenge RM et al. (2007) Two independent alleles at 6q23 associated with risk of rheumatoid arthritis. Nat. Genet. 39:1477–82.CrossRefPubMedPubMedCentralGoogle Scholar
  7. 7.
    Jawaheer D et al. (2003) Screening the genome for rheumatoid arthritis susceptibility genes: a replication study and combined analysis of 512 multicase families. Arthritis Rheum. 48:906–16.CrossRefPubMedGoogle Scholar
  8. 8.
    Cornelis F et al. (1998) New susceptibility locus for rheumatoid arthritis suggested by a genome-wide linkage study. Proc. Natl. Acad. Sci. U. S. A. 95:10746–50.CrossRefPubMedPubMedCentralGoogle Scholar
  9. 9.
    MacKay K et al. (2002) Whole-genome linkage analysis of rheumatoid arthritis susceptibility loci in 252 affected sibling pairs in the United Kingdom. Arthritis Rheum. 46 632–9.CrossRefPubMedGoogle Scholar
  10. 10.
    Stastny P. (1976) Mixed lymphocyte cultures in rheumatoid arthritis. J. Clin. Invest. 57:1148–57.CrossRefPubMedPubMedCentralGoogle Scholar
  11. 11.
    Gregersen PK, Silver J, Winchester RJ. (1987) The shared epitope hypothesis. An approach to understanding the molecular genetics of susceptibility to rheumatoid arthritis. Arthritis Rheum. 30:1205–13.CrossRefPubMedGoogle Scholar
  12. 12.
    Hall FC et al. (1996) Influence of the HLA-DRB1 locus on susceptibility and severity in rheumatoid arthritis. Qjm. 89:821–9.CrossRefPubMedGoogle Scholar
  13. 13.
    Gourraud PA et al. (2006) A new classification of HLA-DRB1 alleles differentiates predisposing and protective alleles for rheumatoid arthritis structural severity. Arthritis Rheum. 54:593–9.CrossRefPubMedGoogle Scholar
  14. 14.
    Mulcahy B et al. (1996) Genetic variability in the tumor necrosis factor-lymphotoxin region influences susceptibility to rheumatoid arthritis. Am. J. Hum. Genet. 59:676–83.PubMedPubMedCentralGoogle Scholar
  15. 15.
    Ota M et al. (2001) A second susceptibility gene for developing rheumatoid arthritis in the human MHC is localized within a 70-kb interval telomeric of the TNF genes in the HLA class III region. Genomics. 71:263–70.CrossRefPubMedGoogle Scholar
  16. 16.
    Jawaheer D et al. (2002) Dissecting the genetic complexity of the association between human leukocyte antigens and rheumatoid arthritis. Am. J. Hum. Genet. 71:585–94.CrossRefPubMedPubMedCentralGoogle Scholar
  17. 17.
    Newton JL et al. (2004) Dissection of class III major histocompatibility complex haplotypes associated with rheumatoid arthritis. Arthritis Rheum 50:2122–9.CrossRefPubMedGoogle Scholar
  18. 18.
    Jawaheer D, Lum RF, Amos CI, Gregersen PK, Criswell LA. (2004) Clustering of disease features within 512 multicase rheumatoid arthritis families. Arthritis Rheum. 50:736–41.CrossRefPubMedGoogle Scholar
  19. 19.
    Wolfe F, Michaud K, Gefeller O, Choi HK. (2003) Predicting mortality in patients with rheumatoid arthritis. Arthritis Rheum. 48:1530–42.CrossRefPubMedGoogle Scholar
  20. 20.
    Fries JF et al. (2002) HLA-DRB1 genotype associations in 793 white patients from a rheumatoid arthritis inception cohort: frequency, severity, and treatment bias. Arthritis Rheum. 46:2320–9.CrossRefPubMedGoogle Scholar
  21. 21.
    Irigoyen P et al. (2005) Regulation of anti-cyclic citrullinated peptide antibodies in rheumatoid arthritis: Contrasting effects of HLA-DR3 and the shared epitope alleles. Arthritis Rheum. 52:3813–8.CrossRefPubMedGoogle Scholar
  22. 22.
    Mitchell MK, Gregersen PK, Johnson S, Parsons R, Vlahov D. (2004) The New York Cancer Project: rationale, organization, design, and baseline characteristics. J. Urban Health. 81:301–10.CrossRefPubMedPubMedCentralGoogle Scholar
  23. 23.
    Erlich H et al. (1991) HLA-DR, DQ and DP typing using PCR amplification and immobilized probes. Eur. J. Immunogenet. 18:33–55.CrossRefPubMedGoogle Scholar
  24. 24.
    Tian C et al. (2008) Analysis and Application of European Genetic Substructure Using 300 K SNP Information. PLoS. Genet. 4:e4.CrossRefPubMedPubMedCentralGoogle Scholar
  25. 25.
    Price P et al. (1999) The genetic basis for the association of the 8.1 ancestral haplotype (A1, B8, DR3) with multiple immunopathological diseases. Immunol. Rev. 167:257–74.CrossRefPubMedGoogle Scholar
  26. 26.
    Price AL, Patterson NJ, Plenge RM, Weinblatt ME, Shadick NA, Reich D. (2006) Principal components analysis corrects for stratification in genome-wide association studies. Nat. Genet. 38:904–9.CrossRefPubMedGoogle Scholar
  27. 27.
    Traherne JA et al. (2006) Genetic analysis of completely sequenced disease-associated MHC haplotypes identifies shuffling of segments in recent human history. PLoS. Genet. 2:e9.CrossRefPubMedPubMedCentralGoogle Scholar
  28. 28.
    Moxley G, Cohen HJ. (2002) Genetic studies, clinical heterogeneity, and disease outcome studies in rheumatoid arthritis. Rheum. Dis. Clin. North Am. 28:39–58.CrossRefPubMedGoogle Scholar
  29. 29.
    Graham RR et al. (2002) Visualizing human leukocyte antigen class II risk haplotypes in human systemic lupus erythematosus. Am. J. Hum. Genet. 71:543–53.CrossRefPubMedPubMedCentralGoogle Scholar
  30. 30.
    Vandiedonck C et al. (2004) Pleiotropic effects of the 8.1 HLA haplotype in patients with autoimmune myasthenia gravis and thymus hyperplasia. Proc. Natl. Acad. Sci. U. S. A. 101:15464–9.CrossRefPubMedPubMedCentralGoogle Scholar
  31. 31.
    Alper CA et al. (1989) Genetic prediction of non-response to hepatitis B vaccine. N. Engl. J. Med. 321:708–12.CrossRefPubMedGoogle Scholar
  32. 32.
    Caruso C et al. (1997) HLA-B8,DR3 haplotype affects lymphocyte blood levels. Immunol. Invest. 26:333–40.CrossRefPubMedGoogle Scholar
  33. 33.
    Caruso C, Bellina L. (1983) B8, DR3 antigens and production of human leucocyte migration inhibitory factor (LIF) by mononuclear cells stimulated with concanavalin A (Con A). Tissue Antigens. 22:167–9.CrossRefPubMedGoogle Scholar
  34. 34.
    Candore G, Cigna D, Gervasi F, Colucci AT, Modica MA, Caruso C. (1994) In vitro cytokine production by HLA-B8,DR3 positive subjects. Autoimmunity. 18:121–32.CrossRefPubMedGoogle Scholar
  35. 35.
    Single RM et al. (2007) Global diversity and evidence for coevolution of KIR and HLA. Nat. Genet. 39:1114–9.CrossRefPubMedGoogle Scholar
  36. 36.
    Yen JH et al. (2001) Major histocompatibility complex class I-recognizing receptors are disease risk genes in rheumatoid arthritis. J. Exp. Med. 193:1159–67.CrossRefPubMedPubMedCentralGoogle Scholar
  37. 37.
    Middleton D, Meenagh A, Wright GD. (2007) No association in frequency of KIR receptors in patients with rheumatoid arthritis from Northern Ireland. Tissue Antigens. 69:577–82.CrossRefPubMedGoogle Scholar
  38. 38.
    Martin MP et al. (2002) Cutting edge: susceptibility to psoriatic arthritis: influence of activating killer Ig-like receptor genes in the absence of specific HLA-C alleles. J. Immunol. 169:2818–22.CrossRefPubMedGoogle Scholar
  39. 39.
    Martin MP et al. (2007) Innate partnership of HLA-B and KIR3DL1 subtypes against HIV-1. Nat Genet. 39:733–40.CrossRefPubMedPubMedCentralGoogle Scholar
  40. 40.
    Butsch Kovacic M et al. (2005) Variation of the killer cell immunoglobulin-like receptors and HLA-C genes in nasopharyngeal carcinoma. Cancer Epidemiol. Biomarkers Prev. 14:2673–7.CrossRefPubMedGoogle Scholar
  41. 41.
    Hiby SE et al. (2004) Combinations of maternal KIR and fetal HLA-C genes influence the risk of preeclampsia and reproductive success. J. Exp. Med. 200:957–65.CrossRefPubMedPubMedCentralGoogle Scholar

Copyright information

© Feinstein Institute for Medical Research 2008

Authors and Affiliations

  • Hye-Soon Lee
    • 1
    • 2
    • 10
  • Annette T. Lee
    • 1
    • 10
  • Lindsey A. Criswell
    • 3
    • 10
  • Michael F. Seldin
    • 4
    • 10
  • Christopher I. Amos
    • 5
    • 10
  • John P. Carulli
    • 6
    • 10
  • Cristina Navarrete
    • 7
    • 10
  • Elaine F. Remmers
    • 8
    • 10
  • Daniel L. Kastner
    • 8
    • 10
  • Robert M. Plenge
    • 9
    • 10
  • Wentian Li
    • 1
    • 10
  • Peter K. Gregersen
    • 1
    • 10
  1. 1.Feinstein Institute for Medical Research, North Shore LIJ Health SystemRobert S. Boas Center for Genomics and Human GeneticsManhassetUSA
  2. 2.Hanyang University College of MedicineSeoulSouth Korea
  3. 3.The University of California San FranciscoSan FranciscoUSA
  4. 4.the University of California DavisDavisUSA
  5. 5.M.D. Anderson Cancer CenterThe University of TexasHoustonUSA
  6. 6.Biogen Idec Inc.CambridgeUSA
  7. 7.National Blood ServiceLondonUK
  8. 8.The National Institute of Arthritis and Musculoskeletal and Skin DiseasesBethesdaUSA
  9. 9.The Broad Institute of Harvard and the Massachusetts Institute of TechnologyCambridgeUSA
  10. 10.Division of Rheumatology, Immunology and Allergy, Department of MedicineBrigham and Women’s Hospital, Harvard Medical SchoolBostonUSA

Personalised recommendations